

share
Pagibaximab CAS NO 595566-61-3
Unit Price:
CAS No.:595566-61-3
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Pagibaximab is a monoclonal antibody specifically developed for the prevention of serious infections in high-risk patient populations. This product is critical for ensuring patient safety and improving clinical outcomes in controlled medical environments. It is primarily utilized by pharmaceutical manufacturers, clinical research organizations, and healthcare institutions involved in advanced therapeutic development and prophylactic care.
Application
- Pharmaceutical Active Ingredient (API): Serves as the primary active component in the formulation of finished injectable drug products.
- Clinical Research & Development: Used in preclinical and clinical trials to evaluate efficacy and safety profiles for new medical indications.
- Prophylactic Treatment Formulations: Incorporated into solutions designed for the prevention of specific infections in immunocompromised patients.
- Biologics Manufacturing: A key intermediate in the large-scale production of biologic drugs under Good Manufacturing Practice (GMP) conditions.
- Reference Standard: Employed as a high-purity standard in analytical laboratories for quality control and assay development.
Basic Information
| Product Name | Pagibaximab |
| CAS No. | 595566-61-3 |
| Molecular Formula | Contact for details |
| Molecular Weight | Contact for details |
| Synonyms | BSYX-A110; Pagibaximab (BSYX-A110); Anti-Lipoteichoic Acid Monoclonal Antibody; Human Monoclonal Antibody to Lipoteichoic Acid; Monoclonal Antibody BSYX-A110; Pagibaximab [USAN]; UNII-9Q5FKL8C4S |
| EINECS | Contact for details |
Quality Control
Our Pagibaximab is manufactured and tested to meet stringent pharmaceutical-grade standards. Each batch undergoes comprehensive analytical testing, including purity assay, identity confirmation, and impurity profiling, to ensure compliance with relevant pharmacopeial guidelines. A Certificate of Analysis (COA) documenting all test results is provided with every shipment to guarantee traceability and quality assurance.
Storage
Preserve in a tightly closed container, protected from light. Store at 2-8°C. This product is hygroscopic (moisture-sensitive) and must be protected from humidity. For long-term storage, consider conditions recommended for biological materials.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or solid |
| Identification (HPLC/MS) | Conforms to reference standard |
| Assay (HPLC) | ≥ 95.0% |
| Protein Content | Contact for details |
| Purity (SEC-HPLC) | Monomer ≥ 98.0% |
| Endotoxin | < 1.0 EU/mg |
| Sterility | Sterile (where applicable) |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






